MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TN-02-0160594
Tablets Medopharm Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹18.97 Cr
▲ 63% YoY
Net loss · FY 2025
₹3.45 Cr
Net margin -18.2%
EBITDA · FY 2025
-₹4.34 Cr
EBITDA margin -22.9%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹9.77 Cr
Issued & subscribed
Open charges
₹4.5 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
14
Provident fund records
About Tablets Medopharm Private Limited
Data last updated:
Tablets Medopharm Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2019PTC130558. Its GSTIN is 33AAHCT4274H1Z9 (Tamil Nadu).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹9.77 Cr. It is led by directors including Tushar Chordia (Whole-Time Director) and Hastimal Chordia.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.3B R.A.Building 2nd Floor Old No.19 New No.72 Marshalls Road Egmore, Chennai, Tamil Nadu, India – 600008.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.97 Cr, a growth of 63% compared to the previous year. For the same year it recorded a net loss of ₹3.45 Cr (net margin -18.2%) and EBITDA of -₹4.34 Cr (EBITDA margin -22.9%). Revenue has grown at a compounded annual rate (CAGR) of 97% over three years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.5 Cr on record. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2021.
Tablets Medopharm Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TN-02-0160594). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tabletsmedo.com.
Company details
CIN U51909TN2019PTC130558
Registration Number 130558
Incorporation Date 17 July 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TN-02-0160594
Key People
Tushar Chordia Whole-Time Director Hastimal Chordia Director Balamurugan Rengasamy Director Recognitions & Rankings of Tablets Medopharm
Contact details
Tablets Medopharm Private Limited's registered office is in Chennai, Tamil Nadu. Its website is tabletsmedo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.3B R.A.Building 2nd Floor Old No.19 New No.72 Marshalls Road Egmore, Chennai, Tamil Nadu, India – 600008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tablets Medopharm Private Limited, buy the company report.
Comprehensive company report
Tablets Medopharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Tablets Medopharm is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tablets Medopharm Private Limited, buy the company report.
Financials of Tablets Medopharm Private Limited
FY 2025 filings availableTablets Medopharm Private Limited reported revenue of ₹18.97 Cr (up 63% YoY) for FY 2025.
Revenue · FY 2025
₹18.97 Cr ▲ 63%
Net loss · FY 2025
₹3.45 Cr margin -18.2%
EBITDA · FY 2025
-₹4.34 Cr margin -22.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 97%
EBITDA CAGR growth
1 year
▼ 120%
3 years · compounded
▼ 7%
5 years · compounded
▼ 58%
Revenue has grown at a compounded annual rate (CAGR) of 97% over three years, including 63% growth in the latest year. EBITDA fell 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.45 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -22.9% | ||||
| Net Profit Margin | -18.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tablets Medopharm Private Limited, buy the company report.
Board of directors of Tablets Medopharm Private Limited
Tablets Medopharm has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hastimal Chordia | Director | 20 Mar 2024 | 2 Years 7 Months | Current |
| Balamurugan Rengasamy Also directs: Tablets Globalcare Private Limited | Director | 01 Nov 2019 | 6 Years 11 Months | Current |
| Tushar Chordia | Whole-Time Director | 01 Nov 2019 | 6 Years 11 Months | Current |
| Siddhartha Daga Also directs: Daga Shelters LLP, Daga Shelters Private Limited | Director | 01 Nov 2019 | 6 Years 11 Months | Current |
Auditor
Tablets Medopharm Private Limited is audited by KOCHAR S AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOCHAR S AND ASSOCIATES | FY 2024 | 024590S |
Shareholding
The shareholding of Tablets Medopharm Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tablets Medopharm Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Aug 2023 | 100777684 | Hdfc Bank Limited | ₹4.5 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Tablets Medopharm Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2021.
Total deals
3
Rights issues
2
Secondary share transfer
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Rights issue | ₹5 Cr | Investors: Medopharm Private Limited , Tablets (India) Ltd , 2 individuals |
| Nov 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2019 | Rights issue | ₹1.99 Cr | Investors: Medopharm Private Limited , Tablets (India) Ltd , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Tablets Medopharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tablets Medopharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tablets Medopharm Private Limited has a workforce of 14 employees on its EPFO records as of May 26, 2025, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
Employee growth
7.69%
GST
Tablets Medopharm has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCT4274H1Z9 | Tamil Nadu | Active | 30 Jul 2019 |
To see the full GST registrations and return filing status of Tablets Medopharm Private Limited, buy the company report.
Recent activity
Tablets Medopharm Private Limited has 13 board changes on record since 2019: 4 appointments and 9 cessations. The latest: Hastimal Chordia ceased to be Additional Director on 27 Sep 2024.
AGM
Tablets Medopharm Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Filing
Tablets Medopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Hastimal Chordia ceased to be Additional Director.
Appointed
Hastimal Chordia was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.50 Cr with Charge ID 100777684 was registered on 22 Aug 2023.
Ceased
Tushar Chordia ceased to be Director.
Ceased
Balamurugan Rengasamy ceased to be Additional Director.
Ceased
Dewashish Prasad Shrivastava ceased to be Additional Director.
Ceased
Siddhartha Daga ceased to be Additional Director.
Appointed
Balamurugan Rengasamy was appointed as Director.
Ceased
Bharat Jhaver ceased to be Additional Director.
Ceased
Dhruv Narayan Purohit ceased to be Director.
5 earlier events are in the company report.
Frequently asked questions
Tablets Medopharm is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 July 2019 (7+ years old) and is registered under CIN U51909TN2019PTC130558.
Tablets Medopharm has 4 current directors:
- Tushar Chordia - Whole-Time Director
- Hastimal Chordia - Director
- Balamurugan Rengasamy - Director
- Siddhartha Daga - Director
The latest financial statements of Tablets Medopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Tablets Medopharm is 33AAHCT4274H1Z9, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Tablets Medopharm is U51909TN2019PTC130558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tablets Medopharm was incorporated on 17 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Tablets Medopharm has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in February 2021.
Hastimal Chordia ceased to be Additional Director on 27 Sep 2024. Hastimal Chordia was appointed as Director on 20 Mar 2024. Tushar Chordia ceased to be Director on 01 Dec 2020. Tablets Medopharm has 13 board changes on record in total.
Yes, Tablets Medopharm is registered as an MSME under Udyam registration (number: UDYAM-TN-02-0160594).
Tablets Medopharm can be reached through the website tabletsmedo.com. Its registered office is in Chennai, Tamil Nadu, India.